Keith Ward to Lead Little Rock's InterveXion Therapeutics

InterveXion Therapeutics of Little Rock, a private clinical-stage biopharmaceutical company focused on developing immunotherapies for substance abuse disorders, announced Monday the appointment of Keith Ward, Ph.D., to president and CEO.
Source: Arkansas Business - Health Care - Category: American Health Source Type: news